SmallCap
CompaniesMapStatistics

(주)와이바이오로직스

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Company Name(주)와이바이오로직스
English NameY-Biologics, Inc
Business Reg. No.3148195083
CEO박영우, 장우익
Address대전광역시 유성구 테크로 4로 17, 비715호
Industry의학 및 약학 연구개발업
Industry Code70113
Established20071231
Phone042-867-9971
Websiteybiologics.com
Regular Employees46persons
Corp. Reg. No.1601110235641

Investment Metrics


Market Cap
-
Op. Margin
-146.58%
ROE
-35.1%
Debt Ratio
18.37%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2009-06-22 ~ 2011-06-21200901058802009-06-22
기술평가보증기업(기금)2011-07-22 ~ 2013-07-21201101046652009-06-22
기술평가보증기업(기금)2013-07-22 ~ 2015-07-21201301072212009-06-22
기술평가보증기업(기금)2015-07-22 ~ 2017-07-21201501085602009-06-22
연구개발유형2017-07-22 ~ 2019-07-21201701096772009-06-22
연구개발유형2019-07-22 ~ 2021-07-21201901099652009-06-22
연구개발유형2021-07-22 ~ 2024-07-21202108260200452009-06-22
연구개발유형2024-07-22 ~ 2027-07-21202407300200242009-06-22

Financial Statements


3-Year Financial Data

Revenue CAGR +17.8%

Item202420232022
Revenue

58B

35B

42B

Operating Profit

-84B

-101B

-188B

Net Profit

-64B

-209B

-188B

Total Assets

217B

303B

293B

Total Liabilities

34B

69B

170B

Total Equity

184B

234B

123B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
58B

51.1%

vs. 3-Year Avg.: 38B
Operating Profit
-84B

41.7%

vs. 3-Year Avg.: -145B
Op. Margin
-146.6%

60.7%

vs. 3-Year Avg.: -372.6%
Debt Ratio
18.4%

78.1%

vs. 3-Year Avg.: 84.0%
ROE
-35.1%

71.0%

vs. 3-Year Avg.: -121.1%

Officers / Major Shareholders


NamePositionRoleComp. (M KRW)
박영우사내이사경영총괄-
장우익사내이사경영총괄-
박범찬사내이사개발본부본부장-
이상헌미등기개발실장-
윤주한미등기연구소장-
이경호미등기경영관리실장-
장명자미등기IP센터장-
유병주사외이사사외이사-
이종오감사감사-
ShareholderOwnership (%)Shares Held
-
-
-
-
-
-
-

Employment Status


NPS Subscribers

55persons

CEO박영우, 장우익
Est. Avg. Annual Salary

5,96810K

(49710K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+5persons

Left (12 mo)

-2persons

Net Change (12 mo)

+3persons

NPS Join Date

2008-01-01

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "대전광역시 유성구 테크노4로",
  "brno": "314819****",
  "cappedWarning": false,
  "companyName": "주식회사 와이바이오로직스",
  "estimatedAvgAnnualSalary": 59676948,
  "estimatedAvgMonthlySalary": 4973079,
  "fetchedAt": "2026-03-05T19:05:57.280Z",
  "industryCode": "730000",
  "industryName": "기타 인문 및 사회과학 연구개발업",
  "joinDate": "20080101",
  "last12MonthsHired": 5,
  "last12MonthsLeft": 2,
  "last12MonthsNetChange": 3,
  "leaveDate": null,
  "monthlyPensionAmount": 25984340,
  "monthlyTrend": [
    {
      "lostSubscribers": 2,
      "newSubscribers": 5,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6375949",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 55,
  "turnoverMonths": 1
}

{
  "address": "대전광역시 유성구",
  "ceo_name": "박영우, 장우익",
  "certificate": [
    {
      "cert_number": "20090105880",
      "changes": "",
      "disclosure_date": "2009-06-22",
      "first_cert_date": "2009-06-22",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2009-06-22 ~ 2011-06-21"
    },
    {
      "cert_number": "20110104665",
      "changes": "",
      "disclosure_date": "2011-07-22",
      "first_cert_date": "2009-06-22",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2011-07-22 ~ 2013-07-21"
    },
    {
      "cert_number": "20130107221",
      "changes": "",
      "disclosure_date": "2013-07-15",
      "first_cert_date": "2009-06-22",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2013-07-22 ~ 2015-07-21"
    },
    {
      "cert_number": "20150108560",
      "changes": "",
      "disclosure_date": "2015-08-18",
      "first_cert_date": "2009-06-22",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2015-07-22 ~ 2017-07-21"
    },
    {
      "cert_number": "20170109677",
      "changes": "",
      "disclosure_date": "2017-08-21",
      "first_cert_date": "2009-06-22",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2017-07-22 ~ 2019-07-21"
    },
    {
      "cert_number": "20190109965",
      "changes": "",
      "disclosure_date": "2019-08-28",
      "first_cert_date": "2009-06-22",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2019-07-22 ~ 2021-07-21"
    },
    {
      "cert_number": "20210826020045",
      "changes": "",
      "disclosure_date": "2021-08-26",
      "first_cert_date": "2009-06-22",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2021-07-22 ~ 2024-07-21"
    },
    {
      "cert_number": "20240730020024",
      "changes": "",
      "disclosure_date": "2024-07-30",
      "first_cert_date": "2009-06-22",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2024-07-22 ~ 2027-07-21"
    }
  ],
  "company_name": "주식회사 와이바이오로직스",
  "financials": {
    "2022": {
      "capital_stock": 6145164000,
      "cost_of_sales": 2814101000,
      "current_assets": 18033782000,
      "current_liabilities": 16195420000,
      "gross_profit": 1336457000,
      "net_income": -18804402000,
      "net_income_bs": -18804401000,
      "non_current_assets": 11288867000,
      "non_current_liabilities": 834062000,
      "non_operating_expenses": 692764000,
      "non_operating_income": 718577000,
      "operating_profit": -18830215000,
      "revenue": 4150558000,
      "sga_expenses": 20166672000,
      "total_assets": 29322649000,
      "total_equity": 12293167000,
      "total_liabilities": 17029482000
    },
    "2023": {
      "capital_stock": 7381363000,
      "cost_of_sales": 1090103000,
      "current_assets": 21762540000,
      "current_liabilities": 5507822000,
      "gross_profit": 2388978000,
      "net_income": -20871054000,
      "net_income_bs": -20871053000,
      "non_current_assets": 8531474000,
      "non_current_liabilities": 1377731000,
      "non_operating_expenses": 11677279000,
      "non_operating_income": 948918000,
      "operating_profit": -10142693000,
      "revenue": 3479081000,
      "sga_expenses": 12531670000,
      "total_assets": 30294014000,
      "total_equity": 23408461000,
      "total_liabilities": 6885553000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "phone": "042-867-****",
  "source": "pg_migration"
}

Data Sources


Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsDART
Collected
Investment MetricsDART
Collected
OfficersDART
Collected
EmploymentDART
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
Venture System Detail2026-03-05
Collected
DART Financial2026-02-27
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
Employment Insurance2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected